294 results on '"Weller, Johannes"'
Search Results
2. Functional outcome after late cranioplasty after decompressive craniectomy: a single-center retrospective study
3. Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infection
4. Endovascular treatment of primary M3 occlusion stroke in clinical practice: analysis of the German Stroke Registry
5. Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment
6. Prevalence and prognostic relevance of invasive fungal disease during veno-arterial ECMO: A retrospective single-center study
7. Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial
8. The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial
9. Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses
10. Unplanned intensive care unit readmission after surgical treatment in patients with newly diagnosed glioblastoma — forfeiture of surgically achieved advantages?
11. Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis
12. Outcome of Stroke Patients with Unknown Onset and Unknown Time Last Known Well Undergoing Endovascular Therapy
13. Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial
14. Mechanical Thrombectomy in Patients with Acute Ischemic Stroke and Concomitant Intracranial Hemorrhage
15. Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses
16. Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS
17. Arginase-1 Released into CSF After Aneurysmal Subarachnoid Hemorrhage Decreases Arginine/Ornithine Ratio: a Novel Prognostic Biomarker
18. Perioperative red blood cell transfusion is associated with poor functional outcome and overall survival in patients with newly diagnosed glioblastoma
19. Antithrombotic treatment and outcome after endovascular treatment and acute carotid artery stenting in stroke patients with atrial fibrillation
20. Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial
21. Machine learning models for outcome prediction in thrombectomy for large anterior vessel occlusion.
22. Clinical significance and prevalence of subarachnoid hyperdensities on flat detector CT after mechanical thrombectomy: does it really matter?
23. Tumor-associated epilepsy in patients with brain metastases: necrosis-to-tumor ratio forecasts postoperative seizure freedom
24. RTMS of the Cerebellum Using an Accelerated Stimulation Protocol Improved Gait in Parkinson’s Disease
25. Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment
26. The patients’ perspective on the burden of idiopathic intracranial hypertension
27. Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival
28. Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
29. Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
30. Successful mechanical thrombectomy in stroke with thrombolysis-associated intracerebral hemorrhage—a case report
31. Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia.
32. Endovascular Treatment for Acute Stroke in Cerebral Amyloid Angiopathy
33. Frequency and Characteristics of Spinal Bleeding Sources in Nontraumatic Angiogram-Negative Subarachnoid Hemorrhage
34. Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial
35. Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia
36. Surgery for temporal glioblastoma: lobectomy outranks oncosurgical-based gross-total resection
37. Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial
38. Clinical significance and prevalence of subarachnoid hyperdensities on flat detector CT after mechanical thrombectomy: does it really matter?
39. P133/254 Clinical significance of subarachnoid hyper densities on flat panel CT after mechanical thrombectomy – does it matter?
40. COVID-19 Is an Independent Risk Factor for Detrimental Invasive Fungal Disease in Patients on Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Study
41. Additive prognostic impact of the cerebrospinal fluid arginine/ornithine ratio to established clinical scores in aneurysmal subarachnoid hemorrhage
42. The Diagnostic Value of Cerebrospinal Fluid Lactate for Detection of Sepsis in Community-Acquired Bacterial Meningitis
43. Supplemental Figure 1 from Diagnosis of Pseudoprogression Following Lomustine–Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
44. Targeted anticonvulsive treatment of IDH-wildtype glioblastoma based on DNA methylation subclasses
45. A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression
46. Intravenous thrombolysis upon flow restoration improves outcome in endovascular thrombectomy.
47. NIMG-32. POSTPROGRESSION SURVIVAL AND MRI FEATURES AT PROGRESSION IN MGMT-METHYLATED GLIOBLASTOMA FOLLOWING TEMOZOLOMIDE (TMZ) OR CCNU/TMZ THERAPY - AN ANALYSIS OF THE CETEG/NOA-09-TRIAL
48. CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT
49. Intravenous thrombolysis upon flow restoration improves outcome in endovascular thrombectomy
50. Prognostic impact of early intracranial haemorrhage in bacterial meningitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.